153 related articles for article (PubMed ID: 10380089)
1. Effects of inhaled beclomethasone compared to systemic dexamethasone on lung inflammation in preterm infants at risk of chronic lung disease.
Groneck P; Goetze-Speer B; Speer CP
Pediatr Pulmonol; 1999 Jun; 27(6):383-7. PubMed ID: 10380089
[TBL] [Abstract][Full Text] [Related]
2. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2012 May; (5):CD002058. PubMed ID: 22592683
[TBL] [Abstract][Full Text] [Related]
3. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
4. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR
Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
[TBL] [Abstract][Full Text] [Related]
6. Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia.
Gupta GK; Cole CH; Abbasi S; Demissie S; Njinimbam C; Nielsen HC; Colton T; Frantz ID
Pediatr Pulmonol; 2000 Oct; 30(4):275-81. PubMed ID: 11015126
[TBL] [Abstract][Full Text] [Related]
7. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah V; Ohlsson A; Halliday HL; Dunn MS
Cochrane Database Syst Rev; 2000; (2):CD001969. PubMed ID: 10796275
[TBL] [Abstract][Full Text] [Related]
8. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease.
Groneck P; Reuss D; Götze-Speer B; Speer CP
J Pediatr; 1993 Jun; 122(6):938-44. PubMed ID: 8388949
[TBL] [Abstract][Full Text] [Related]
9. Effect of inhaled corticosteroids on markers of pulmonary inflammation and lung maturation in preterm infants with evolving chronic lung disease.
Parikh NA; Locke RG; Chidekel A; Leef KH; Emberger J; Paul DA; Stefano JL
J Am Osteopath Assoc; 2004 Mar; 104(3):114-20. PubMed ID: 15083986
[TBL] [Abstract][Full Text] [Related]
10. Meter-dosed, inhaled beclomethasone attenuates bronchoalveolar oxyradical inflammation in premature infants at risk for bronchopulmonary dysplasia.
Zimmerman JJ; Gabbert D; Shivpuri C; Kayata S; Ciesielski W; Miller J; Peters ME; Eissenstat RP; Shen G
Am J Perinatol; 1998; 15(10):567-76. PubMed ID: 9926878
[TBL] [Abstract][Full Text] [Related]
11. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.
Groneck P; Götze-Speer B; Oppermann M; Eiffert H; Speer CP
Pediatrics; 1994 May; 93(5):712-8. PubMed ID: 8165067
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of inhaled versus intravenous steroids in ventilator-dependent preterm infants.
Suchomski SJ; Cummings JJ
J Perinatol; 2002; 22(3):196-203. PubMed ID: 11948381
[TBL] [Abstract][Full Text] [Related]
13. Tracheobronchial aspirate fluid neutrophil lipocalin, elastase- and neutrophil protease-4-alpha1-antitrypsin complexes, protease inhibitors and free proteolytic activity in respiratory distress syndrome.
Sveger T; Ohlsson K; Polberger S; Noack G; Mörse H; Laurin S
Acta Paediatr; 2002; 91(9):934-7. PubMed ID: 12412868
[TBL] [Abstract][Full Text] [Related]
14. Early postnatal dexamethasone therapy for the prevention of chronic lung disease.
Vermont Oxford Network Steroid Study Group
Pediatrics; 2001 Sep; 108(3):741-8. PubMed ID: 11533345
[TBL] [Abstract][Full Text] [Related]
15. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
16. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants.
Subhedar NV; Ryan SW; Shaw NJ
Arch Dis Child Fetal Neonatal Ed; 1997 Nov; 77(3):F185-90. PubMed ID: 9462187
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity.
Kovács L; Davis GM; Faucher D; Papageorgiou A
Acta Paediatr; 1998 Jul; 87(7):792-8. PubMed ID: 9722255
[TBL] [Abstract][Full Text] [Related]
18. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial.
Bloomfield FH; Knight DB; Harding JE
J Pediatr; 1998 Sep; 133(3):395-400. PubMed ID: 9738724
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
Halliday HL; Patterson CC; Halahakoon CW;
Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
[TBL] [Abstract][Full Text] [Related]
20. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
Halliday HL; Ehrenkranz RA; Doyle LW
Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
